US opens trade probe against Germany over pharma pricing
USTR says Germany's underpayment for innovative medicines burdens US commerce, risking fresh tariffs as Berlin seeks to cut insurer drug costs.
Original Source
Read the full article at Citizen →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.